U.S. Other Utilities Stock News

Why Fox (FOXA) is on investors’ radar Fox (FOXA) has drawn attention after a period where the share price showed mixed short term moves, including a one month gain alongside a past three month decline, prompting investors to reassess the media group’s fundamentals. See our latest analysis for Fox. At a share price of $57.82, Fox has recently seen modest short term share price gains alongside a weaker 90 day share price return and stronger multi year total shareholder returns, suggesting...

Earlier this month, Varonis Systems launched Varonis Atlas, an end-to-end AI security platform that discovers, secures, and monitors AI systems across the enterprise, integrating with its existing data security suite and offering a free trial for capabilities such as AI posture management, runtime guardrails, and compliance reporting. This move extends Varonis beyond data protection into full AI lifecycle security, potentially deepening its role in how enterprises safely operationalize AI...

JPMorgan Chase has launched a pilot tool that electronically audits junior bankers’ reported working hours. The system compares self reported hours with estimates from digital activity such as video calls, keyboard use, and meeting schedules. The pilot is designed to increase transparency around workloads and work life balance for junior staff. For investors tracking NYSE:JPM, this move comes as the bank trades at a share price of $286.56 and has returned 21.0% over the past year and 109.8%...

Earlier this week, Rhythm Pharmaceuticals announced that the FDA approved an expanded indication for IMCIVREE (setmelanotide) to treat adults and children aged 4 and older with acquired hypothalamic obesity, the first authorized therapy for this rare, injury‑related form of obesity. The approval, supported by the Phase 3 TRANSCEND trial showing a placebo‑adjusted reduction in body mass index and immediate U.S. availability, materially broadens IMCIVREE’s eligible patient pool and reinforces...

UnitedHealth Group (UNH) has drawn fresh attention after a stretch of weak share performance, with the stock showing declines over the past week, month, past 3 months and year. This has prompted investors to reassess the business. See our latest analysis for UnitedHealth Group. With the share price at $275.59 after a 90 day share price return of 15.8% decline and a 1 year total shareholder return of 45.2% decline, recent weakness suggests momentum has been fading as investors reassess risks...

On March 19, 2026, Box, Inc. announced that its Board of Directors expanded the share repurchase program by US$500 million, bringing total authorization to about US$1.86 billion and extending the program through September 30, 2027. This larger, longer buyback plan underlines management’s confidence in Box’s financial position and capital returns alongside its Intelligent Content Management strategy. Next, we’ll examine how Box’s expanded US$1.86 billion repurchase authorization may influence...

On 19 March 2026, X-energy Reactor Company and Talen Energy signed a Letter of Intent to assess deploying X-energy's Xe-100 small modular reactors in Pennsylvania and across the PJM market, including feasibility studies, site evaluations, and potential conversion of fossil-fired sites. This early-stage alliance highlights Talen’s interest in advanced nuclear as a potential replacement for fossil generation, reusing existing grid connections and workforce while pursuing cleaner baseload...

Event context and recent share performance SoundHound AI (SOUN) has attracted attention recently after a period of volatile trading, with the stock showing a return of about 2,107% over 3 years, alongside weaker performance over the past year and month. See our latest analysis for SoundHound AI. Despite a very large 3 year total shareholder return, recent momentum has faded, with a 1 day share price return of 5.09% decline adding to a 90 day share price return of 40.79% decline as investors...

Framing Essential Properties Realty Trust (EPRT) after recent returns Essential Properties Realty Trust (EPRT) has drawn attention after a 4.3% total return over the past 3 months and 5.5% year to date, prompting closer inspection of its recent share performance and fundamentals. See our latest analysis for Essential Properties Realty Trust. At a share price of $31.71, EPRT’s 1-day share price return of 2.64% and 7-day share price return of 3.73% soften its 4.27% 90-day share price gain,...

Entergy highlighted its support for workforce development and community resilience at the Dress for Success New Orleans event. Company leaders and employees participated in the event, underscoring involvement in local career readiness efforts. For investors watching Entergy (NYSE:ETR), this kind of community engagement sits alongside a share price of $99.9 and a value score of 3. The stock has seen a 6.4% return year to date and a 22.4% return over the past year, which gives added context...

If you are wondering whether Crane NXT at around US$40.37 is a bargain or a value trap, starting with a clear view of what the current price actually reflects can help. The stock has been under pressure recently, with a 4.5% decline over the last 7 days, 23.7% over the last 30 days, and 22.8% over the past year, which may signal shifting expectations around risk and future returns. Recent coverage has focused on Crane NXT's position in its sector, its capital allocation decisions, and how...

Axcelis Technologies (NasdaqGS: ACLS) will serve as the Diamond Sponsor of the Compound Semiconductor Asia Conference (CS Asia) 2026 during SEMICON China. The company plans to launch its next generation Purion Power Series+ Platform for chipmakers in China at the event. Axcelis CEO Mary Puma is scheduled to deliver a keynote address to industry participants and customers. Axcelis Technologies focuses on ion implantation and related processing equipment for the semiconductor sector, with...

Wondering if Independent Bank at around US$74.70 is offering fair value, or if the recent price leaves too little upside on the table. The stock has returned 22.6% over the past year, with a 2.1% gain year to date, even though the last 30 days saw a 9.2% pullback and the past week was roughly flat at a 0.1% decline. Recent market attention on Independent Bank has focused on its share price performance and how it compares with peers in the banking sector. Investors have been weighing whether...

Global Ship Lease (NYSE:GSL) files a new US$229 million Shelf Registration. The company also publishes its 2025 Annual Report, covering recent fleet acquisitions and charter activity. Both filings offer fresh detail on capital plans, fleet growth, and charter coverage for the year ahead. Global Ship Lease focuses on owning and chartering containerships, so its funding plans and fleet moves matter directly for earnings power and balance sheet risk. The new US$229 million Shelf Registration...

In recent days, commentary on Trimble has highlighted that its geospatial technology business has faced a 2.8% annual revenue decline over the past two years, as customers postponed purchases and organic growth weakened. This pattern, alongside higher capital requirements and softer free cash flow margins, raises questions about whether Trimble will need acquisitions to reinvigorate its core operations. We’ll now examine how Trimble’s revenue declines and softer organic growth might affect...

On 10 March 2026, Nu Holdings Ltd. appointed former TikTok global head of creators Kim Farrell as its new global marketing director, tasking her with shaping Nubank's worldwide branding and overseeing campaigns as the company expands beyond Latin America, including into the U.S. This hire signals Nu’s intention to compete as a recognisable global consumer brand, not just a regional fintech, by pairing marketing leadership with its recently elevated U.S. CEO Cristina Junqueira. Next, we’ll...

SELLAS Life Sciences Group (NasdaqCM:SLS) has begun a Phase 2 trial of SLS009 in first line acute myeloid leukemia (AML), targeting high risk patient subgroups. The company plans to present new preclinical data for SLS009, including activity in difficult to treat AML mutations, at an upcoming AACR meeting. SELLAS is progressing toward the final analysis of the Phase 3 REGAL trial of its GPS cancer vaccine in AML, with trial oversight ongoing and positive trends in patient outcomes...

BitFuFu (NasdaqCM:FUFU) closed out FY 2025 with Q4 revenue of US$101.7 million and a basic EPS loss of US$0.60, compared with Q4 FY 2024 revenue of US$99.2 million and EPS of US$0.14. Trailing twelve month EPS for Q4 stood at a loss of US$0.35 on revenue of US$475.8 million. Over the past year, quarterly revenue has ranged from US$78.0 million to US$180.7 million and quarterly basic EPS has swung between a loss of US$0.60 and a profit of US$0.29, underscoring how sensitive profitability...

With no single headline event driving attention to Ascendis Pharma (NasdaqGS:ASND) today, the focus for investors leans toward how its recent share performance and financial profile might fit into a high-risk, high-reward biotech allocation. See our latest analysis for Ascendis Pharma. At a share price of $221.88, Ascendis Pharma has given investors a 10.95% 3 month share price return and a 33.67% 1 year total shareholder return. This reinforces a longer term total shareholder return of...

SoFi Technologies (NasdaqGS:SOFI) ranked #1 in the 2026 J.D. Power U.S. Investor Satisfaction Study. The top spot covers SoFi’s digital investment platform, ahead of traditional brokers and fintech competitors. The recognition focuses on investor satisfaction with SoFi’s digital first experience for DIY trading and investing. For SoFi Technologies, best known for its digital financial services ecosystem, this recognition relates directly to its push into investing alongside lending and...

If you are wondering whether HubSpot at around US$258.81 is a bargain or a value trap, you are not alone. That is exactly what this article will unpack. The stock has moved around recently, with a 2.1% decline over the past week, a 3.5% gain over the last 30 days, and returns of 32.3% decline year to date and 57.3% decline over the past year that may have shifted how investors view its risk and potential. Recent commentary around HubSpot has focused on how the business fits into broader...

Why Prologis (PLD) is on investors’ radar today Recent share performance has put Prologis (PLD) in focus, with the stock showing a 2.3% decline over the past day and an 8.3% decline over the past month, while the past 3 months sit slightly positive. See our latest analysis for Prologis. At a share price of $128.01, Prologis has seen weaker short term share price momentum, with a 30 day share price return of 8.3% and a slightly negative year to date performance, while the 1 year total...

If you are wondering whether Peloton Interactive at around US$3.84 is a bargain or a value trap, starting with a clear look at what the current share price actually reflects can help sharpen your view. The stock has recently returned 3.5% over 7 days, while the 30 day, year to date and 1 year returns sit at an 11.1% decline, 37.3% decline and 44.8% decline respectively, so recent moves may say as much about changing risk perception as they do about the underlying business. Recent headlines...

Hartford Insurance Group (NYSE:HIG) has been named the top performing company in the Insurance category in Just Capital's 2026 rankings for sustainability and stakeholder performance. The company was also recognized as one of the World’s Most Ethical Companies by Ethisphere for the 17th time, one of only two honorees in its sector for 2026. These recognitions highlight Hartford Insurance Group's focus on ethics, stakeholder value and sustainability practices. For investors watching...